Holen Sie sich die Stockscreener-App
5.7899
5.12%
-0.3001
Schlusskurs vom Vortag:
$6.09
Offen:
$6.145
24-Stunden-Volumen:
44.92M
Relative Volume:
1.66
Marktkapitalisierung:
$2.47B
Einnahmen:
$64.60M
Nettoeinkommen (Verlust:
$-377.75M
KGV:
-3.7354
EPS:
-1.55
Netto-Cashflow:
$-335.64M
1W Leistung:
+4.68%
1M Leistung:
+22.94%
6M Leistung:
+24.26%
1J Leistung:
-6.05%
1-Tages-Spanne:
$5.705
$6.18
1-Wochen-Bereich:
$5.11
$6.30
52-Wochen-Spanne:
$3.79
$12.36
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
Firmenname
Recursion Pharmaceuticals Inc
Sektor
Branche
Telefon
(385) 269-0203
Adresse
41S RIO GRANDE STREET, SALT LAKE CITY
Vergleichen Sie RXRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
5.7866 | 2.66B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
414.76 | 107.98B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.67 | 59.07B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.93 | 59.76B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
803.67 | 49.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
334.64 | 38.56B | 4.56B | -176.77M | 225.30M | -1.7177 |
Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-03-16 | Eingeleitet | Needham | Buy |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-03-04 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-09-21 | Eingeleitet | Berenberg | Buy |
| 2021-05-11 | Eingeleitet | BofA Securities | Buy |
| 2021-05-11 | Eingeleitet | Goldman | Neutral |
| 2021-05-11 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2021-05-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Recursion Pharmaceuticals Inc Aktie (RXRX) Neueste Nachrichten
Recursion Pharmaceuticals: Recent Gains Mysterious Given Lack Of Overall Progress (RXRX) - Seeking Alpha
Recursion Pharmaceuticals Stock (RXRX) Opinions on Recent Price Momentum - Quiver Quantitative
AI Drug Discovery Goldmine? Inside Recursion Pharma’s Wild Stock Surge and What’s Next - ts2.tech
Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today - AOL.com
Using economic indicators to assess Recursion Pharmaceuticals Inc. potential2025 Market Overview & Real-Time Volume Analysis - newser.com
Why Recursion Pharmaceuticals Stock Tanked on Tuesday - MSN
COST, AMD, RXRX, CIFR, SNOW: 5 Trending Stocks TodayAdvanced Micro Devices (NASDAQ:AMD) - Benzinga
What's Going On With Recursion Pharmaceuticals Stock On Wednesday? - Benzinga
Recursion Pharmaceuticals Shares Surge Amid Strategic Growth - TipRanks
AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025 - ts2.tech
Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory - Yahoo Finance
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know - sharewise.com
RXRX Shares Plunge: Time to Bail Out? - StocksToTrade
Needham Reiterates a Buy on Recursion Pharmaceuticals (RXRX) - MSN
Can Recursion Pharmaceuticals Inc. recover in the next quarterJuly 2025 Analyst Calls & Safe Capital Allocation Plans - newser.com
Custom strategy builders for tracking Recursion Pharmaceuticals Inc.2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
How to recover losses in Recursion Pharmaceuticals Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - newser.com
Is Recursion Pharmaceuticals Inc. still worth holding after the dip2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
Will Recursion Pharmaceuticals Inc. stock recover faster than market2025 Big Picture & Entry and Exit Point Strategies - newser.com
Should you wait for a breakout in Recursion Pharmaceuticals Inc.Trade Entry Summary & Real-Time Buy Zone Alerts - newser.com
Biotech Stocks To Watch NowOctober 4th - MarketBeat
Why Recursion Pharmaceuticals (RXRX) Is Up 19.2% After Securing $12.5M Milestone in AI Drug Partnership - simplywall.st
Biotech Stocks To ResearchOctober 3rd - MarketBeat
Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains? - Yahoo Finance
Evaluating Recursion After a 19% Rally Amid Renewed Interest in Biotech AI Initiatives - Yahoo Finance
Recursion Pharmaceuticals (RXRX): Assessing Valuation Following New Milestone Payment and Drug Development Progress - simplywall.st
Smart tools for monitoring Recursion Pharmaceuticals Inc.’s price actionWeekly Profit Summary & Weekly Momentum Picks - newser.com
Published on: 2025-10-03 01:30:40 - newser.com
Published on: 2025-10-02 22:53:16 - newser.com
Recursion Pharmaceuticals, Inc. (RXRX) Expands Rare Disease Pipeline with REV102 Acquisition - MSN
Best Biotech Stocks To Watch NowOctober 2nd - MarketBeat
Recursion Pharmaceuticals Inc. (RXRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
RXRX’s Market Moves: A Deep Dive - timothysykes.com
Recursion Pharmaceuticals’ Bold Strategy: A Gamechanger? - StocksToTrade
Recursion Pharmaceuticals Stock (RXRX) Opinions on $12.5M Milestone Payment - Quiver Quantitative
Published on: 2025-09-30 19:47:45 - newser.com
Jim Cramer on Recursion: “I Need to See a Proof of Concept Here” - MSN
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years - AOL.com
Finanzdaten der Recursion Pharmaceuticals Inc-Aktie (RXRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.84%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):